Coordinación para la Innovación y la Aplicación de la Ciencia y la Tecnología, Universidad Autónoma de San Luis Potosí, SLP, México.
Skin Res Technol. 2011 Feb;17(1):45-50. doi: 10.1111/j.1600-0846.2010.00461.x.
Filaggrin (FLG) gene mutations, which result in complete or incomplete loss of proFLG/FLG peptides, have been reported as an important predisposing factor for atopic dermatitis (AD) and secondary atopic phenotypes such as atopic asthma.
The presence of the protein FLG in the skin was evaluated at birth on 12 infants using Raman spectroscopy; these 12 infants were monitored for 1 year to see whether they developed AD. Three different statistical analysis procedures, two of which involved principal component analysis (PCA), were performed on the Raman spectra in order to determine the FLG content.
The infants who had a lower FLG content, determined using any of the three statistical analysis procedures proposed, were also the ones that clinically developed AD.
The results suggest that Raman spectroscopy and statistical analysis such as PCA could be used as an early detection procedure for FLG -related AD and as a possible quantitative marker for FLG gene mutations.
丝聚蛋白(FLG)基因突变会导致前丝聚蛋白/FLG 肽完全或部分缺失,被认为是特应性皮炎(AD)和特应性哮喘等次要特应性表型的重要易感因素。
采用拉曼光谱法在 12 名婴儿出生时评估皮肤中 FLG 蛋白的存在情况,对这 12 名婴儿进行了 1 年的监测,以观察他们是否患有 AD。对拉曼光谱进行了三种不同的统计分析程序,其中两种涉及主成分分析(PCA),以确定 FLG 含量。
使用三种提出的统计分析程序中的任何一种程序确定的 FLG 含量较低的婴儿,也会在临床上出现 AD。
结果表明,拉曼光谱和 PCA 等统计分析可作为与 FLG 相关的 AD 的早期检测程序,也可能作为 FLG 基因突变的定量标志物。